Main Article Content
and Eudragit NE 30 D were used as release retarding coating polymers. The release retarding capability of these polymers was also investigated. In each case, 10% polymer on dry basis was loaded. The flow property, surface roughness as well as the drug release behavior of the pellets was found to be the subject of types of polymers. About 35% drug was released at the first hour in 0.1N HCl media (pH 1.2) from Eudragit RL 30 D-coated pellets but from Eudragit RS 30 D and Eudragit NE 30 D-coated pellets, only 13.75 and 2.43% drug was released, respectively. In buffer media (pH 6.8), about 54% drug was released at the first hour from Eudragit RL 30 D-coated pellets but only 64% drug was released at 10 h. From Eudragit RL 30 D- and Eudragit NE 30 D-coated pellets only 7.28 and 1.14% drug was released at 1 h, respectively, but about 5.14 and 5.86 h was required for 50% drug release from these two polymers and about 80% drug was released at 10 h.The functional groups present in the polymeric films played a significant role on in vitro release kinetics of the drug from the coated pellets. Different kinetic models like zero order, first order and Higuchi were used for fitting the drug release pattern. The Higuchi model was the best fitted for ambroxol release from the coated pellets. The drug release mechanism
was derived with Korsmeyer equation.
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.
Fekete R, ZelkÃ³ R, Marton S, RÃ¡cz I. Effect of the formulation parameters
on the characteristics of pellets. Drug Dev Ind Pharm 1998;24:1073-6.
Vergote GJ, Vervaet C, van Driessche I, Hoste S, de Smedt S, Demeester J,
et al. An oral controlled release matrix pellet formulation containing
nanocrystalline ketoprofen. Int J Pharm 2001;219:81-7.
Krogars K, HeinÃ¤mÃ¤ki J, Vesalahti J, Marvola M, Antikainen O, Yliruusi J.
Extrusion-spheronization of pH-sensitive polymeric matrix pellets for
possible colonic drug delivery. Int J Pharm 2000;199:187-94.
Hileman GA, Upadrashta SM, Neau SH. Drug solubility effects on
predicting optimum conditions for extrusion and spheronization of
pellets. Pharm Dev Technol 1997;2:43-52.
Thoma K, Ziegler I. Investigations on the influence of the type of
extruder for pelletization by extrusion-spheronization. II. Sphere
characteristics. Drug Dev Ind Pharm 1998;24:413-22.
Kleinebudde P, SchrÃ¶der M, Schultz P, MÃ¼ller BW, Waaler T, Nymo L.
Importance of the fraction of microcrystalline cellulose and
spheronization speed on the properties of extruded pellets made from
binary mixtures. Pharm Dev Technol 1999;4:397-404.
Wu C, McGinity JW. Influence of ibuprofen as a solid-state plasticizer in
Eudragit RS 30 D on the physicochemical properties of coated beads.
AAPS PharmSciTech 2001;2:24.
Okor RS, Obi CE. Drug release through aqueous-based film coatings of
acrylate-methacrylate, a water-insoluble copolymer. Int J Phamaceutics
Lehmann K, Dreher D. Coating of tablets and small particles with
acrylic resins by fluid bed technology. Int J Pharm Technol Prod Manuf
Kibbe AH. Handbook of Pharmaceutical Excipients. 3 ed. American
Pharmaceutical Association and Pharmaceutical Press; 2000. p. 401-3.
Lehmann K. Chemistry and application properties of polymethacrylate
coating system. In: Aqueous polymeric coating for pharmaceutical
dosage forms. 2 ed. Marcel Decker Inc; 1996. p. 101-74.
Lin AY, Muhammad NA, Pope D, Augsburger LL. Effect of curing and
storage conditions on drug release from pellets coated with Eudragit
NE30D. AAPS PharmSci 2000;2.
Lin AY, Muhammad NA, Pope D, Augsburger LL. Study of crystal
lization of endogenous surfactant in Eudragit NE 30D-free films
and its influence on drug-release properties of controlled-release
diphenhydramine HCl pellets coated with Eudragit NE30D. AAPS
Barar FSK. Essentials of Pharmacotherapeutics. 3 ed. S Chand and
Company Ltd., New Delhi; 2005. p. 550.
Martindale SC. The Complete Drug Reference. 33 ed. The Pharmaceutical
Press, London; 2002. p. 1084.
. Vergin H, Bishop-Freudling GB, Miczka M, Nitsche V, Strobel K,
Matzkies F. The pharmacokinetics and bioequivalence of various dosage
forms of ambroxol. Arzneimittelforschung 1985;35:1591.
Alighieri T, Avanessian S, Berlini S, Bianchi SG, Deluigi P, Valducci R,
et al. Arzneim Forsch. Drug Res 1988;38:92.
Ahmed I, Roni MA, Kibria G, Islam MR, Rahman MH. Effect of plastic
and acrylic polymers on the release profile of ambroxol hydrochloride
controlled release pellets prepared by extrusion-spheronization
technique and fluid bed coating. Dhaka Univ J Pharm Sci 2008;7:181-6.
Kibria G, Islam KM, Jalil RU. Stability study of ambroxol hydrochloride
sustained release pellets coated with acrylic polymer. Pak J Pharm Sci
Lehmann K, Abmus M, Bossler H, Dreher D, Liddiard C, Petereit H,
et al. Controlled drug release through film coatings. In: Practical course
in film coating of pharmaceutical dosage forms with Eudragit. Rohm
GmbH and Co. Germany; 2001. p. 8-15.
Kibria G, Ul-Jalil R. The effect of the ratio of two acrylic polymers on
the in vitro release kinetics of ketoprofen from pellets prepared by
extrusion and spheronisation technique. Pak J Pharm Sci 2008;21:92-7.
â€œNews Pharma Polymersâ€ Bulletin. Rohm GmbH and Co. Germany;